Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 3Breast Neoplasms 3Stomatitis 2Neoplasms 2Mucositis 2Vulvodynia 1Urologic Neoplasms 1Urologic Diseases 1Urolithiasis 1Urinary Bladder Neoplasms 1Urinary Bladder Diseases 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Skin Neoplasms 1Pain, Postoperative 1Pain 1Non-Muscle Invasive Bladder Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Multiple Endocrine Neoplasia Type 1 1Mobility Limitation 1MRSA Colonization 1Lymphoma 1Leukemia 1Ilues 1Hydronephrosis 1Hematologic Diseases 1Head and Neck Neoplasms 1Dyspareunia 1Disease 1

Interventions

Dexamethasone 5Magnetic Resonance Spectroscopy 4Cyclophosphamide 4Blood Specimen Collection 4Surveys and Questionnaires 3Prednisone 3Melphalan 3Lenalidomide 3Biopsy, Fine-Needle 3fluciclovine F-18 2carfilzomib 2Positron-Emission Tomography 2Mammography 2Injections 2Immunohistochemistry 2Gemcitabine 2Cytarabine 22-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2weifuchun 1vistusertib 1venetoclax 1technetium 99m 1-(1-(2-(bis(carboxymethyl)amino)-2-oxoethyl)-1H-imidazol-2-yl)-2-((1-(2-(bis(carboxymethyl)amino)-2-oxoethyl)-1H-imidazol-2-yl)methyl)-9,14-dioxo-2,8,13,15-tetraazaoctadecane-7,12,16,18-tetracarboxylic acid) 1ricolinostat 1pomalidomide 1phosphoribosylformylglycinamidine synthetase 1pembrolizumab 1ofatumumab 1obinutuzumab 1lortalamine 1irinotecan sucrosofate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Disease × Water × Clear all
NCT01844375 2019-11-04

A Trial of Preoperative CHO Drinks on Postoperative Walking Capacity in Colorectal Surgery

Siriraj Hospital

Phase NA Completed
70 enrolled 10 charts
Gastrointestinal

Disease, Colorectal Neoplasms, Mobility Limitation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡